These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 33846607)

  • 1. How could a COVID vaccine cause blood clots? Scientists race to investigate.
    Ledford H
    Nature; 2021 Apr; 592(7854):334-335. PubMed ID: 33846607
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID vaccines and blood clots: what researchers know so far.
    Ledford H
    Nature; 2021 Aug; 596(7873):479-481. PubMed ID: 34429544
    [No Abstract]   [Full Text] [Related]  

  • 3. Portal Vein Thrombosis due to Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) after Covid Vaccination with ChAdOx1 nCoV-19.
    Strobel D; Haberkamp S; Zundler S
    Ultraschall Med; 2021 Oct; 42(5):551-552. PubMed ID: 34598301
    [No Abstract]   [Full Text] [Related]  

  • 4. Strategies to Prevent SARS-CoV-2-Mediated Eosinophilic Disease in Association with COVID-19 Vaccination and Infection.
    Simon HU; Karaulov AV; Bachmann MF
    Int Arch Allergy Immunol; 2020; 181(8):624-628. PubMed ID: 32544911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination.
    Fueyo-Rodriguez O; Valente-Acosta B; Jimenez-Soto R; Neme-Yunes Y; Inclán-Alarcón SI; Trejo-Gonzalez R; García-Salcido MÁ
    BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 34059544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral venous thrombosis after COVID-19 vaccination: is the risk of thrombosis increased by intravascular application of the vaccine?
    Gürtler L; Seitz R; Schramm W
    Infection; 2021 Oct; 49(5):1071-1074. PubMed ID: 34286453
    [No Abstract]   [Full Text] [Related]  

  • 7. Case study of thrombosis and thrombocytopenia syndrome following administration of the AstraZeneca COVID-19 vaccine.
    Saleh A; Collins J
    Aust J Gen Pract; 2021 Nov; 50():. PubMed ID: 34781321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. All eyes on a hurdle race for a SARS-CoV-2 vaccine.
    Gaebler C; Nussenzweig MC
    Nature; 2020 Oct; 586(7830):501-502. PubMed ID: 33077943
    [No Abstract]   [Full Text] [Related]  

  • 9. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [SARS-CoV-2 vaccine-induced immune thrombosis and thrombocytopenia].
    Hvas AM; Ostrowski SR; Frederiksen H; Kampmann P; Stensballe J
    Ugeskr Laeger; 2021 Jul; 183(29):. PubMed ID: 34356021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mix-and-match COVID vaccines trigger potent immune response.
    Callaway E
    Nature; 2021 May; 593(7860):491. PubMed ID: 34012131
    [No Abstract]   [Full Text] [Related]  

  • 12. "Let me choose my COVID-19 vaccine".
    Dal-Ré R; Stephens R; Sreeharan N
    Eur J Intern Med; 2021 May; 87():104-105. PubMed ID: 33581978
    [No Abstract]   [Full Text] [Related]  

  • 13. Thrombosis in peripheral artery disease and thrombotic thrombocytopenia after adenoviral COVID-19 vaccination.
    Crea F
    Eur Heart J; 2021 Oct; 42(39):3995-3999. PubMed ID: 34649281
    [No Abstract]   [Full Text] [Related]  

  • 14. Thrombosis with thrombocytopenia syndrome after COVID-19 vaccination.
    Cuker A
    Clin Adv Hematol Oncol; 2021 Jul; 19(7):446-449. PubMed ID: 34236343
    [No Abstract]   [Full Text] [Related]  

  • 15. SARS-CoV-2 vaccines-induced thrombotic thrombocytopenia: should we consider immuno-hypersensitivity?
    Reuben RC; Adogo LY
    Rev Saude Publica; 2021; 55():70. PubMed ID: 34730750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the dynamics of COVID-19; implications for therapeutic intervention, vaccine development and movement control.
    Salvamani S; Tan HZ; Thang WJ; Ter HC; Wan MS; Gunasekaran B; Rhodes A
    Br J Biomed Sci; 2020 Oct; 77(4):168-184. PubMed ID: 32942955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2.
    Plotkin SA
    J Pediatric Infect Dis Soc; 2020 Nov; 9(5):517-518. PubMed ID: 32744616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombotic Thrombocytopenia and Central Venous Sinus Thrombosis Post - COVID-19 Vaccination and its Treatment with Heparin Alternatives.
    Sheikh S
    J Coll Physicians Surg Pak; 2021 Jul; 31(7):149. PubMed ID: 34271824
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of vaccines for SARS-CoV-2.
    Ng WH; Liu X; Mahalingam S
    F1000Res; 2020; 9():. PubMed ID: 32850116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.